A comparison of the effects of flubendazole and thiabendazole on the larvae of Angiostrongylus cantonensis, Trichinella spiralis, Diphyllobothrium erinacei and Hymenolepis nana in mice - PubMed (original) (raw)
Comparative Study
A comparison of the effects of flubendazole and thiabendazole on the larvae of Angiostrongylus cantonensis, Trichinella spiralis, Diphyllobothrium erinacei and Hymenolepis nana in mice
J Maki et al. Parasitology. 1983 Dec.
Abstract
Flubendazole or thiabendazole were administered orally to mice harbouring larvae of Angiostrongylus cantonensis, Trichinella spiralis, Diphyllobothrium erinacei or Hymenolepis nana 5-10, 28-33, 21-26 and 1-6 days post-infection respectively. All the mice infected with A. cantonensis were completely cured after treatment with flubendazole at 5 mg/kg/day for 6 days. No noticeable damage was found in the cerebral hemispheres of the mice treated with flubendazole and examined under a dissecting microscope. On the other hand, larvae were found in or on the cerebral hemispheres showing obvious haemorrhage in the control mice. The mice treated with flubendazole gained weight while the control mice lost weight. No larvicidal effect of thiabendazole on A. cantonensis was found at a dose of 10 mg/kg/day for 6 days. The mean reduction of larval T. spiralis in mice treated with flubendazole at 5, 50 and 100 mg/kg/day for 6 days was 64, 100 and 99% respectively. In comparison, thiabendazole showed no efficacy against T. spiralis larvae at 50 or 100 mg/kg/day. Mice harbouring plerocercoids of D. erinacei or H. nana larvae were not cured with either flubendazole or thiabendazole at 50 or 100 mg/kg/day for 6 days.
Similar articles
- Larvicidal effect of flubendazole on Angiostrongylus cantonensis in mice with various worm burdens.
Maki J, Yanagisawa T. Maki J, et al. J Helminthol. 1985 Dec;59(4):301-2. doi: 10.1017/s0022149x00025839. J Helminthol. 1985. PMID: 4093587 - Effect of flubendazole on the number of first-stage larvae of Angiostrongylus cantonensis released in the faeces of treated rats.
Maki J, Yanagisawa T. Maki J, et al. J Helminthol. 1990 Jun;64(2):87-95. doi: 10.1017/s0022149x00011974. J Helminthol. 1990. PMID: 2387978
Cited by
- Clinical Efficacy and Safety of Albendazole and Other Benzimidazole Anthelmintics for Rat Lungworm Disease (Neuroangiostrongyliasis): A Systematic Analysis of Clinical Reports and Animal Studies.
Jacob J, Steel A, Lin Z, Berger F, Zöeller K, Jarvi S. Jacob J, et al. Clin Infect Dis. 2022 Apr 9;74(7):1293-1302. doi: 10.1093/cid/ciab730. Clin Infect Dis. 2022. PMID: 34448480 Free PMC article. Review. - Clinical aspects of eosinophilic meningitis and meningoencephalitis caused by Angiostrongylus cantonensis, the rat lungworm.
Murphy GS, Johnson S. Murphy GS, et al. Hawaii J Med Public Health. 2013 Jun;72(6 Suppl 2):35-40. Hawaii J Med Public Health. 2013. PMID: 23901382 Free PMC article. Review. - Combined treatment with interleukin-12 and mebendazole lessens the severity of experimental eosinophilic meningitis caused by Angiostrongylus cantonensis in ICR mice.
Du WY, Liao JW, Fan CK, Su KE. Du WY, et al. Infect Immun. 2003 Jul;71(7):3947-53. doi: 10.1128/IAI.71.7.3947-3953.2003. Infect Immun. 2003. PMID: 12819081 Free PMC article. - Use of L4 larvae of Nippostrongylus brasiliensis for the in vivo screening of anthelmintic drugs.
Domínguez L, Saldaña J, Chernin J. Domínguez L, et al. Can J Vet Res. 2000 Jul;64(3):160-3. Can J Vet Res. 2000. PMID: 10935881 Free PMC article. - Pathogenic factors in the later pulmonary phase of Angiostrongylus cantonensis-infected rats.
Ishii AI. Ishii AI. Parasitol Res. 1987;73(5):458-65. doi: 10.1007/BF00538205. Parasitol Res. 1987. PMID: 3658975